MedPath

天津市康瑞药业有限公司

Ownership
-
Established
1996-10-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Paracetamol Vitamin C Tablets

Product Name
对乙酰氨基酚维生素C片
Approval Number
国药准字H20080246
Approval Date
Sep 14, 2022
NMPA

Repaglinide Tablets

Product Name
瑞格列奈片
Approval Number
国药准字H20123055
Approval Date
Oct 12, 2021
NMPA

Telmisartan Tablets

Product Name
雪盈平
Approval Number
国药准字H20060488
Approval Date
Apr 9, 2021
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H19983087
Approval Date
Jul 7, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H19983084
Approval Date
Jul 7, 2020
NMPA

Captopril Tablets

Product Name
卡托普利片
Approval Number
国药准字H19983086
Approval Date
Jul 16, 2015
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H19993426
Approval Date
Jul 16, 2015
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H19983085
Approval Date
Jul 16, 2015
NMPA

穿心莲内脂片

Approval Number
国药准字Z20055680
Approval Date
Dec 27, 2005
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.